Understanding resilience

Gang Wu, Adriana Feder, Hagit Cohen, Joanna J Kim, Solara Calderon, Dennis S Charney, Aleksander A Mathé, Gang Wu, Adriana Feder, Hagit Cohen, Joanna J Kim, Solara Calderon, Dennis S Charney, Aleksander A Mathé

Abstract

Resilience is the ability to adapt successfully in the face of stress and adversity. Stressful life events, trauma, and chronic adversity can have a substantial impact on brain function and structure, and can result in the development of posttraumatic stress disorder (PTSD), depression and other psychiatric disorders. However, most individuals do not develop such illnesses after experiencing stressful life events, and are thus thought to be resilient. Resilience as successful adaptation relies on effective responses to environmental challenges and ultimate resistance to the deleterious effects of stress, therefore a greater understanding of the factors that promote such effects is of great relevance. This review focuses on recent findings regarding genetic, epigenetic, developmental, psychosocial, and neurochemical factors that are considered essential contributors to the development of resilience. Neural circuits and pathways involved in mediating resilience are also discussed. The growing understanding of resilience factors will hopefully lead to the development of new pharmacological and psychological interventions for enhancing resilience and mitigating the untoward consequences.

Keywords: PTSD; depression; neurobiology; resilience; stress.

Figures

Figure 1
Figure 1
Promoting resilience in child rearing.

References

    1. Akimova E., Lanzenberger R., Kasper S. (2009). The serotonin-1A receptor in anxiety disorders. Biol. Psychiatry 66, 627–635 10.1016/j.biopsych.2009.03.012
    1. Alim T. N., Feder A., Graves R. E., Wang Y., Weaver J., Westphal M., et al. (2008). Trauma, resilience, and recovery in a high-risk African-American population. Am. J. Psychiatry 165, 1566–1575 10.1176/appi.ajp.2008.07121939
    1. Angelucci F., Brene S., Mathe A. A. (2005). BDNF in schizophrenia, depression and corresponding animal models. Mol. Psychiatry 10, 345–352 10.1038/sj.mp.4001637
    1. Armbruster D., Mueller A., Strobel A., Lesch K. P., Brocke B., Kirschbaum C. (2012). Children under stress - COMT genotype and stressful life events predict cortisol increase in an acute social stress paradigm. Int. J. Neuropsychopharmacol. 15, 1229–1239 10.1017/S1461145711001763
    1. Aston-Jones G., Cohen J. D. (2005). An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu. Rev. Neurosci. 28, 403–450 10.1146/annurev.neuro.28.061604.135709
    1. Autry A. E., Monteggia L. M. (2012). Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol. Rev. 64, 238–258 10.1124/pr.111.005108
    1. Benekareddy M., Vadodaria K. C., Nair A. R., Vaidya V. A. (2011). Postnatal serotonin type 2 receptor blockade prevents the emergence of anxiety behavior, dysregulated stress-induced immediate early gene responses, and specific transcriptional changes that arise following early life stress. Biol. Psychiatry 70, 1024–1032 10.1016/j.biopsych.2011.08.005
    1. Bewernick B. H., Hurlemann R., Matusch A., Kayser S., Grubert C., Hadrysiewicz B., et al. (2010). Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol. Psychiatry 67, 110–116 10.1016/j.biopsych.2009.09.013
    1. Binder E. B., Holsboer F. (2012). Low cortisol and risk and resilience to stress-related psychiatric disorders. Biol. Psychiatry 71, 282–283 10.1016/j.biopsych.2011.12.008
    1. Binder E. B., Nemeroff C. B. (2010). The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol. Psychiatry 15, 574–588 10.1038/mp.2009.141
    1. Binder E. B., Bradley R. G., Liu W., Epstein M. P., Deveau T. C., Mercer K. B., et al. (2008). Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299, 1291–1305 10.1001/jama.299.11.1291
    1. Bjornebekk A., Mathe A. A., Brene S. (2005). The antidepressant effect of running is associated with increased hippocampal cell proliferation. Int. J. Neuropsychopharmacol. 8, 357–368 10.1017/S1461145705005122
    1. Bjornebekk A., Mathe A. A., Brene S. (2006). Running has differential effects on NPY, opiates, and cell proliferation in an animal model of depression and controls. Neuropsychopharmacology 31, 256–264 10.1038/sj.npp.1300820
    1. Blackburn E. H., Epel E. S. (2012). Telomeres and adversity: too toxic to ignore. Nature 490, 169–171 10.1038/490169a
    1. Blasi G., Lo Bianco L., Taurisano P., Gelao B., Romano R., Fazio L., et al. (2009). Functional variation of the dopamine D2 receptor gene is associated with emotional control as well as brain activity and connectivity during emotion processing in humans. J. Neurosci. 29, 14812–14819 10.1523/JNEUROSCI.3609-09.2009
    1. Boldrini M., Hen R., Underwood M. D., Rosoklija G. B., Dwork A. J., Mann J. J., et al. (2012). Hippocampal angiogenesis and progenitor cell proliferation are increased with antidepressant use in major depression. Biol. Psychiatry 72, 562–571 10.1016/j.biopsych.2012.04.024
    1. Bradley R. G., Binder E. B., Epstein M. P., Tang Y., Nair H. P., Liu W., et al. (2008). Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch. Gen. Psychiatry 65, 190–200 10.1001/archgenpsychiatry.2007.26
    1. Brummett B. H., Kuhn C. M., Boyle S. H., Babyak M. A., Siegler I. C., Williams R. B. (2012). Cortisol responses to emotional stress in men: association with a functional polymorphism in the 5HTR2C gene. Biol. Psychol. 89, 94–98 10.1016/j.biopsycho.2011.09.013
    1. Burt K. B., Paysnick A. A. (2012). Resilience in the transition to adulthood. Dev. Psychopathol. 24, 493–505 10.1017/S0954579412000119
    1. Cameron E. L., Fox J. D., Anderson M. S., Cameron C. A. (2010). Resilient youths use humor to enhance socioemotional functioning during a day in the life. J. Adolesc. Res. 25, 716–742
    1. Campbell-Sills L., Cohan S. L., Stein M. B. (2006). Relationship of resilience to personality, coping, and psychiatric symptoms in young adults. Behav. Res. Ther. 44, 585–599 10.1016/j.brat.2005.05.001
    1. Carver C. S., Scheier M. F., Segerstrom S. C. (2010). Optimism. Clin. Psychol. Rev. 30, 879–889
    1. Castren E., Rantamaki T. (2010). The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev. Neurobiol. 70, 289–297 10.1002/dneu.20758
    1. Charney D. S. (2004). Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am. J. Psychiatry 161, 195–216 10.1176/appi.ajp.161.2.195
    1. Chemtob C. M., Tomas S., Law W., Cremniter D. (1997). Postdisaster psychosocial intervention: a field study of the impact of debriefing on psychological distress. Am. J. Psychiatry 154, 415–417
    1. Chesney M. A., Neilands T. B., Chambers D. B., Taylor J. M., Folkman S. (2006). A validity and reliability study of the coping self-efficacy scale. Br. J. Health Psychol. 11, 421–437 10.1348/135910705X53155
    1. Cheung C. K., Yue X. D. (2012). Sojourn students' humor styles as buffers to achieve resilience. Int. J. Intercult. Relat. 36, 353–364
    1. Chhatwal J. P., Stanek-Rattiner L., Davis M., Ressler K. J. (2006). Amygdala BDNF signaling is required for consolidation but not encoding of extinction. Nat. Neurosci. 9, 870–872 10.1038/nn1718
    1. Choi D. C., Maguschak K. A., Ye K., Jang S. W., Myers K. M., Ressler K. J. (2010). Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear. Proc. Natl. Acad. Sci. U.S.A. 107, 2675–2680 10.1073/pnas.0909359107
    1. Cicchetti D., Rogosch F. A. (2012). Gene x Environment interaction and resilience: effects of child maltreatment and serotonin, corticotropin releasing hormone, dopamine, and oxytocin genes. Dev. Psychopathol. 24, 411–427 10.1017/S0954579412000077
    1. Claes S. J. (2004). Corticotropin-releasing hormone (CRH) in psychiatry: from stress to psychopathology. Ann. Med. 36, 50–61
    1. Cohen H., Liu T., Kozlovsky N., Kaplan Z., Zohar J., Mathe A. A. (2012). The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder. Neuropsychopharmacology 37, 350–363 10.1038/npp.2011.230
    1. Colby D. A., Shifren K. (2013). Optimism, mental health, and quality of life: a study among breast cancer patients. Psychol. Health Med. 18, 10–20 10.1080/13548506.2012.686619
    1. Covington H. E., 3rd., Maze I., Sun H., Bomze H. M., Demaio K. D., Wu E. Y., et al. (2011). A role for repressive histone methylation in cocaine-induced vulnerability to stress. Neuron 71, 656–670 10.1016/j.neuron.2011.06.007
    1. Cusi A. M., Nazarov A., Holshausen K., Macqueen G. M., McKinnon M. C. (2012). Systematic review of the neural basis of social cognition in patients with mood disorders. J. Psychiatry Neurosci. 37, 154–169 10.1503/jpn.100179
    1. Dalton G. L., Wang Y. T., Floresco S. B., Phillips A. G. (2008). Disruption of AMPA receptor endocytosis impairs the extinction, but not acquisition of learned fear. Neuropsychopharmacology 33, 2416–2426 10.1038/sj.npp.1301642
    1. Dannlowski U., Stuhrmann A., Beutelmann V., Zwanzger P., Lenzen T., Grotegerd D., et al. (2012). Limbic scars: long-term consequences of childhood maltreatment revealed by functional and structural magnetic resonance imaging. Biol. Psychiatry 71, 286–293 10.1016/j.biopsych.2011.10.021
    1. David D. J., Samuels B. A., Rainer Q., Wang J. W., Marsteller D., Mendez I., et al. (2009). Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62, 479–493 10.1016/j.neuron.2009.04.017
    1. Davidson R. J., McEwen B. S. (2012). Social influences on neuroplasticity: stress and interventions to promote well-being. Nat. Neurosci. 15, 689–695 10.1038/nn.3093
    1. Davis M. (2006). Neural systems involved in fear and anxiety measured with fear-potentiated startle. Am. Psychol. 61, 741–756 10.1037/0003-066X.61.8.741
    1. Donner J., Sipila T., Ripatti S., Kananen L., Chen X., Kendler K. S., et al. (2012). Support for involvement of glutamate decarboxylase 1 and neuropeptide Y in anxiety susceptibility. Am. J. Med. Genet. B Neuropsychiatr. Genet. 159B, 316–327 10.1002/ajmg.b.32029
    1. Dudley K. J., Li X., Kobor M. S., Kippin T. E., Bredy T. W. (2011). Epigenetic mechanisms mediating vulnerability and resilience to psychiatric disorders. Neurosci. Biobehav. Rev. 35, 1544–1551 10.1016/j.neubiorev.2010.12.016
    1. Duman R. S. (2009). Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression. Dialogues Clin. Neurosci. 11, 239–255
    1. Duman R. S., Monteggia L. M. (2006). A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59, 1116–1127 10.1016/j.biopsych.2006.02.013
    1. Dunlop B. W., Nemeroff C. B. (2007). The role of dopamine in the pathophysiology of depression. Arch. Gen. Psychiatry 64, 327–337 10.1001/archpsyc.64.3.327
    1. Duryea E. J., Ransom M. V., English G. (1990). Psychological immunization: theory, research, and current health behavior applications. Health Educ. Q. 17, 169–178
    1. Etkin A., Wager T. D. (2007). Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am. J. Psychiatry 164, 1476–1488 10.1176/appi.ajp.2007.07030504
    1. Farchi M., Gidron Y. (2010). The effects of “psychological inoculation” versus ventilation on the mental resilience of Israeli citizens under continuous war stress. J. Nerv. Ment. Dis. 198, 382–384 10.1097/NMD.0b013e3181da4b67
    1. Feder A., Charney D. S., Collins K. (2011). Neurobiology of resilience, in Resilience and Mental Health, eds Southwick S. M., Litz B. T., Charney D. S., Friedman M. J. (New York, NY: Cambridge University Press; ).
    1. Feder A., Nestler E. J., Charney D. S. (2009). Psychobiology and molecular genetics of resilience. Nat. Rev. Neurosci. 10, 446–457 10.1038/nrn2649
    1. Fleshner M., Maier S. F., Lyons D. M., Raskind M. A. (2011). The neurobiology of the stress-resistant brain. Stress 14, 498–502 10.3109/10253890.2011.596865
    1. Folkman S., Moskowitz J. T. (2000). Positive affect and the other side of coping. Am. Psychol. 55, 647–654 10.1037/0003-066X.55.6.647
    1. Forbes E. E., Dahl R. E. (2012). Research review: altered reward function in adolescent depression: what, when and how? J. Child Psychol. Psychiatry. 53, 3–15 10.1111/j.1469-7610.2011.02477.x
    1. Frankl V. E. (2006). Man's Search for Meaning. Boston, MA: Beacon Press
    1. Franklin T. B., Saab B. J., Mansuy I. M. (2012). Neural mechanisms of stress resilience and vulnerability. Neuron 75, 747–761 10.1016/j.neuron.2012.08.016
    1. Frodl T., O'Keane V. (2012). How does the brain deal with cumulative stress? A review with focus on developmental stress, HPA axis function and hippocampal structure in humans. Neurobiol. Dis. [Epub ahead of print]. 10.1016/j.nbd.2012.03.012
    1. Frustaci A., Pozzi G., Gianfagna F., Manzoli L., Boccia S. (2008). Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits. Neuropsychobiology 58, 163–170 10.1159/000182892
    1. Galatzer-Levy I. R., Bonanno G. A. (2012). Heterogeneous patterns of stress over the four years of college: associations with anxious attachment and ego-resiliency. J. Pers. [Epub ahead of print]. 10.1111/jopy.12010
    1. Gatt J. M., Nemeroff C. B., Dobson-Stone C., Paul R. H., Bryant R. A., Schofield P. R., et al. (2009). Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol. Psychiatry 14, 681–695 10.1038/mp.2008.143
    1. Gatt J. M., Nemeroff C. B., Schofield P. R., Paul R. H., Clark C. R., Gordon E., et al. (2010). Early life stress combined with serotonin 3A receptor and brain-derived neurotrophic factor valine 66 to methionine genotypes impacts emotional brain and arousal correlates of risk for depression. Biol. Psychiatry 68, 818–824 10.1016/j.biopsych.2010.06.025
    1. Gillespie C. F., Phifer J., Bradley B., Ressler K. J. (2009). Risk and resilience: genetic and environmental influences on development of the stress response. Depress. Anxiety 26, 984–992 10.1002/da.20605
    1. Gonzalez-Herero V., Garcia-Martin M. A. (2012). Personality, activities, and well-being: a study based on women in late adulthood. J. Women Aging 24, 152–168 10.1080/08952841.2012.639662
    1. Grassi L., Malacarne P., Maestri A., Ramelli E. (1997). Depression, psychosocial variables and occurrence of life events among patients with cancer. J. Affect. Disord. 44, 21–30
    1. Greenwood B. N., Foley T. E., Day H. E., Campisi J., Hammack S. H., Campeau S., et al. (2003). Freewheel running prevents learned helplessness/behavioral depression: role of dorsal raphe serotonergic neurons. J. Neurosci. 23, 2889–2898
    1. Gross J. J. (2002). Emotion regulation: affective, cognitive, and social consequences. Psychophysiology 39, 281–291 10.1017/S0048577201393198
    1. Hansson A. C., Rimondini R., Heilig M., Mathe A. A., Sommer W. H. (2011). Dissociation of antidepressant-like activity of escitalopram and nortriptyline on behaviour and hippocampal BDNF expression in female rats. J. Psychopharmacol. 25, 1378–1387 10.1177/0269881110393049
    1. Hanton S., Neil R., Evans L. (2013). Hardiness and anxiety interpretation: an investigation into coping usage and effectiveness. Eur. J. Sport Sci. 13, 96–104
    1. Harris A. H., Cronkite R., Moos R. (2006). Physical activity, exercise coping, and depression in a 10-year cohort study of depressed patients. J. Affect. Disord. 93, 79–85 10.1016/j.jad.2006.02.013
    1. Harvey B. H., Shahid M. (2012). Metabotropic and ionotropic glutamate receptors as neurobiological targets in anxiety and stress-related disorders: focus on pharmacology and preclinical translational models. Pharmacol. Biochem. Behav. 100, 775–800 10.1016/j.pbb.2011.06.014
    1. Hauger R. L., Risbrough V., Oakley R. H., Olivares-Reyes J. A., Dautzenberg F. M. (2009). Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann. N.Y. Acad. Sci. 1179, 120–143 10.1111/j.1749-6632.2009.05011.x
    1. Heim C., Shugart M., Craighead W. E., Nemeroff C. B. (2010). Neurobiological and psychiatric consequences of child abuse and neglect. Dev. Psychobiol. 52, 671–690 10.1002/dev.20494
    1. Heinz A., Smolka M. N. (2006). The effects of catechol O-methyltransferase genotype on brain activation elicited by affective stimuli and cognitive tasks. Rev. Neurosci. 17, 359–367
    1. Hernández-Wolfe P. (2010). Altruism born of suffering: how colombian human rights activists transform pain into prosocial action. J. Humanist. Psychol. 51, 229–249
    1. Hill M. N. (2012). Introduction to the special issue on stress, emotional behavior, and the endocannabinoid system: a decade of research. Neuroscience 204, 1–4 10.1016/j.neuroscience.2012.01.038
    1. Hill M. N., Gorzalka B. B. (2009). The endocannabinoid system and the treatment of mood and anxiety disorders. CNS Neurol. Disord. Drug Targets 8, 451–458 10.2174/187152709789824624
    1. Ho Y. C., Wang S. (2010). Adult neurogenesis is reduced in the dorsal hippocampus of rats displaying learned helplessness behavior. Neuroscience 171, 153–161 10.1016/j.neuroscience.2010.08.062
    1. Hoexter M. Q., Fadel G., Felicio A. C., Calzavara M. B., Batista I. R., Reis M. A., et al. (2012). Higher striatal dopamine transporter density in PTSD: an in vivo SPECT study with [(99m)Tc]TRODAT-1. Psychopharmacology (Berl.). 224, 337–345 10.1007/s00213-012-2755-4
    1. Hoge E. A., Austin E. D., Pollack M. H. (2007). Resilience: research evidence and conceptual considerations for posttraumatic stress disorder. Depress. Anxiety 24, 139–152 10.1002/da.20175
    1. Holahan C. J., Moos R. H. (1987). Risk, resistance, and psychological distress: a longitudinal analysis with adults and children. J. Abnorm. Psychol. 96, 3–13 10.1037/0021-843X.96.1.3
    1. Holsboer F., Ising M. (2010). Stress hormone regulation: biological role and translation into therapy. Annu. Rev. Psychol. 61, 81–109, C101–C111. 10.1146/annurev.psych.093008.100321
    1. Janssen J., Hulshoff Pol H. E., De Leeuw F. E., Schnack H. G., Lampe I. K., Kok R. M., et al. (2007). Hippocampal volume and subcortical white matter lesions in late life depression: comparison of early and late onset depression. J. Neurol. Neurosurg. Psychiatr. 78, 638–640 10.1136/jnnp.2006.098087
    1. Jhaveri D. J., Mackay E. W., Hamlin A. S., Marathe S. V., Nandam L. S., Vaidya V. A., et al. (2010). Norepinephrine directly activates adult hippocampal precursors via beta3-adrenergic receptors. J. Neurosci. 30, 2795–2806 10.1523/JNEUROSCI.3780-09.2010
    1. Jones T., Moller M. D. (2011). Implications of hypothalamic-pituitary-adrenal axis functioning in posttraumatic stress disorder. J. Am. Psychiatr. Nurses Assoc. 17, 393–403 10.1177/1078390311420564
    1. Jovanovic T., Norrholm S. D., Blanding N. Q., Phifer J. E., Weiss T., Davis M., et al. (2010). Fear potentiation is associated with hypothalamic-pituitary-adrenal axis function in PTSD. Psychoneuroendocrinology 35, 846–857 10.1016/j.psyneuen.2009.11.009
    1. Karatsoreos I. N., McEwen B. S. (2011). Psychobiological allostasis: resistance, resilience and vulnerability. Trends Cogn. Sci. 15, 576–584 10.1016/j.tics.2011.10.005
    1. Karg K., Burmeister M., Shedden K., Sen S. (2011). The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch. Gen. Psychiatry 68, 444–454 10.1001/archgenpsychiatry.2010.189
    1. Karreman A., Vingerhoets J. J. M. (2012). Attachment and well-being: the mediatingrole of emotionregulation and resilience. Pers. Individ. Dif. 53, 821–826
    1. Kim H. K., Kim S. J., Lee Y. J., Lee H. J., Kang S. G., Choi J. E., et al. (2011a). Influence of the interaction between the serotonin 1A receptor C-1019G polymorphism and negative life stressors on the development of depression. Neuropsychobiology 64, 1–8 10.1159/000322144
    1. Kim M. J., Loucks R. A., Palmer A. L., Brown A. C., Solomon K. M., Marchante A. N., et al. (2011b). The structural and functional connectivity of the amygdala: from normal emotion to pathological anxiety. Behav. Brain Res. 223, 403–410 10.1016/j.bbr.2011.04.025
    1. Kim J. M., Stewart R., Kim S. W., Yang S. J., Shin I. S., Kim Y. H., et al. (2007). Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol. Psychiatry 62, 423–428 10.1016/j.biopsych.2006.11.020
    1. Kirilly E., Gonda X., Bagdy G. (2012). CB1 receptor antagonists: new discoveries leading to new perspectives. Acta Physiol. (Oxf.) 205, 41–60 10.1111/j.1748-1716.2012.02402.x
    1. Kolassa I. T., Kolassa S., Ertl V., Papassotiropoulos A., De Quervain D. J. (2010). The risk of posttraumatic stress disorder after trauma depends on traumatic load and the catechol-o-methyltransferase Val(158)Met polymorphism. Biol. Psychiatry 67, 304–308 10.1016/j.biopsych.2009.10.009
    1. Krystal J. H., Neumeister A. (2009). Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resilience. Brain Res. 1293, 13–23 10.1016/j.brainres.2009.03.044
    1. Lawler C., Ouimette P., Dahlstedt D. (2005). Posttraumatic stress symptoms, coping, and physical health status among university students seeking health care. J. Trauma. Stress 18, 741–750 10.1002/jts.20082
    1. Leontopoulou S. (2010). An exploratory study of altruism in Greek children: relations with empathy, resilience and classroom climate. Psychology 1, 377–385
    1. Li Y., Luikart B. W., Birnbaum S., Chen J., Kwon C. H., Kernie S. G., et al. (2008). TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron 59, 399–412 10.1016/j.neuron.2008.06.023
    1. Liu I. Y., Lyons W. E., Mamounas L. A., Thompson R. F. (2004). Brain-derived neurotrophic factor plays a critical role in contextual fear conditioning. J. Neurosci. 24, 7958–7963 10.1523/JNEUROSCI.1948-04.2004
    1. Liu J. L., Li M., Dang X. R., Wang Z. H., Rao Z. R., Wu S. X., et al. (2009). A NMDA receptor antagonist, MK-801 impairs consolidating extinction of auditory conditioned fear responses in a Pavlovian model. PLoS ONE 4:e7548 10.1371/journal.pone.0007548
    1. Luthar S. S., Barkin S. H. (2012). Are affluent youth truly “at risk”? Vulnerability and resilience across three diverse samples. Dev. Psychopathol. 24, 429–449 10.1017/S0954579412000089
    1. Lyons D. M., Parker K. J., Katz M., Schatzberg A. F. (2009). Developmental cascades linking stress inoculation, arousal regulation, and resilience. Front. Behav. Neurosci. 3:32 10.3389/neuro.08.032.2009
    1. Maag J. W., Kotlash J. (1994). Review of stress inoculation training with children and adolescents. Issues and recommendations. Behav. Modif. 18, 443–469
    1. Maestripieri D., Lindell S. G., Higley J. D. (2007). Intergenerational transmission of maternal behavior in rhesus macaques and its underlying mechanisms. Dev. Psychobiol. 49, 165–171 10.1002/dev.20200
    1. Mahan A. L., Ressler K. J. (2012). Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder. Trends Neurosci. 35, 24–35 10.1016/j.tins.2011.06.007
    1. Maninger N., Wolkowitz O. M., Reus V. I., Epel E. S., Mellon S. H. (2009). Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front. Neuroendocrinol. 30:65–91 10.1016/j.yfrne.2008.11.002
    1. Maren S. (2008). Pavlovian fear conditioning as a behavioral assay for hippocampus and amygdala function: cautions and caveats. Eur. J. Neurosci. 28, 1661–1666 10.1111/j.1460-9568.2008.06485.x
    1. Markopoulou K., Papadopoulos A., Juruena M. F., Poon L., Pariante C. M., Cleare A. J. (2009). The ratio of cortisol/DHEA in treatment resistant depression. Psychoneuroendocrinology 34, 19–26 10.1016/j.psyneuen.2008.08.004
    1. Masi G., Brovedani P. (2011). The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression. CNS Drugs 25, 913–931 10.2165/11595900-000000000-00000
    1. Masten A. S. (2001). Ordinary magic. Resilience processes in development. Am. Psychol. 56, 227–238 10.1037/0003-066X.56.3.227
    1. Mathew S. J., Shah A., Lapidus K., Clark C., Jarun N., Ostermeyer B., et al. (2012). Ketamine for treatment-resistant unipolar depression: current evidence. CNS Drugs 26, 189–204 10.2165/11599770-000000000-00000
    1. Mathews D. C., Henter I. D., Zarate C. A. (2012). Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date. Drugs 72, 1313–1333 10.2165/11633130-000000000-00000
    1. McAllister A. K. (2002). Spatially restricted actions of BDNF. Neuron 36, 549–550 10.1016/S0896-6273(02)01063-2
    1. McCormack K., Sanchez M. M., Bardi M., Maestripieri D. (2006). Maternal care patterns and behavioral development of rhesus macaque abused infants in the first 6 months of life. Dev. Psychobiol. 48, 537–550 10.1002/dev.20157
    1. McDevitt R. A., Hiroi R., Mackenzie S. M., Robin N. C., Cohn A., Kim J. J., et al. (2011). Serotonin 1B autoreceptors originating in the caudal dorsal raphe nucleus reduce expression of fear and depression-like behavior. Biol. Psychiatry 69, 780–787 10.1016/j.biopsych.2010.12.029
    1. McGowan P. O., Sasaki A., D'Alessio A. C., Dymov S., Labonte B., Szyf M., et al. (2009). Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 12, 342–348 10.1038/nn.2270
    1. McGowan P. O., Suderman M., Sasaki A., Huang T. C., Hallett M., Meaney M. J., et al. (2011). Broad epigenetic signature of maternal care in the brain of adult rats. PLoS ONE 6:e14739 10.1371/journal.pone.0014739
    1. McRae K., Ciesielski B., Gross J. J. (2012). Unpacking cognitive reappraisal: goals, tactics, and outcomes. Emotion 12, 250–255 10.1037/a0026351
    1. McRae K., Ochsner K. N., Mauss I. B., Gabrieli J. D., Gross J. J. (2008). Gender differences in emotion regulation: an fMRI study of cognitive reappraisal. Group Process. Intergr. Relat. 11, 143–162
    1. Merali Z., Du L., Hrdina P., Palkovits M., Faludi G., Poulter M. O., et al. (2004). Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J. Neurosci. 24, 1478–1485 10.1523/JNEUROSCI.4734-03.2004
    1. Min J. A., Jung Y. E., Kim D. J., Yim H. W., Kim J. J., Kim T. S., et al. (2012). Characteristics associated with low resilience in patients with depression and/or anxiety disorders. Qual. Life Res. [Epub ahead of print]. 10.1007/s11136-012-0153-3
    1. Monk C. S., Klein R. G., Telzer E. H., Schroth E. A., Mannuzza S., Moulton J. L., et al. (2008). Amygdala and nucleus accumbens activation to emotional facial expressions in children and adolescents at risk for major depression. Am. J. Psychiatry 165, 90–98 10.1176/appi.ajp.2007.06111917
    1. Moos R. H., Schaefer J. A. (1993). Coping resources and processes: current concepts and measures, in Handbook of Stress, 2nd Edn. eds Goldberger L., Breznitz S. (New York, NY: The Free Press; ), 234–257
    1. Morgan C. A., 3rd., Rasmusson A. M., Wang S., Hoyt G., Hauger R. L., Hazlett G. (2002). Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report. Biol. Psychiatry 52, 136–142
    1. Morgan C. A., 3rd., Southwick S., Hazlett G., Rasmusson A., Hoyt G., Zimolo Z., et al. (2004). Relationships among plasma dehydroepiandrosterone sulfate and cortisol levels, symptoms of dissociation, and objective performance in humans exposed to acute stress. Arch. Gen. Psychiatry 61, 819–825 10.1001/archpsyc.61.8.819
    1. Morgan C. A., 3rd., Wang S., Southwick S. M., Rasmusson A., Hazlett G., Hauger R. L., et al. (2000). Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biol. Psychiatry 47, 902–909
    1. Morishima Y., Schunk D., Bruhin A., Ruff C. C., Fehr E. (2012). Linking brain structure and activation in temporoparietal junction to explain the neurobiology of human altruism. Neuron 75, 73–79 10.1016/j.neuron.2012.05.021
    1. Murgatroyd C., Spengler D. (2012). Genetic variation in the epigenetic machinery and mental health. Curr. Psychiatry Rep. 14, 138–149 10.1007/s11920-012-0255-1
    1. Murrough J. W., Charney D. S. (2010). Cracking the moody brain: lifting the mood with ketamine. Nat. Med. 16, 1384–1385 10.1038/nm1210-1384
    1. Nemeroff C. B., Vale W. W. (2005). The neurobiology of depression: inroads to treatment and new drug discovery. J. Clin. Psychiatry 66Suppl. 7, 5–13
    1. Nestler E. J., Carlezon W. A., Jr. (2006). The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry 59, 1151–1159 10.1016/j.biopsych.2005.09.018
    1. Numakawa T., Suzuki S., Kumamaru E., Adachi N., Richards M., Kunugi H. (2010). BDNF function and intracellular signaling in neurons. Histol. Histopathol. 25, 237–258
    1. ó Hartaigh B., Loerbroks A., Thomas G. N., Engeland C. G., Hollands M. A., Fischer J. E., et al. (2012). Age-dependent and -independent associations between depression, anxiety, DHEAS, and cortisol: from the MIPH Industrial Cohort Studies (MICS). Psychoneuroendocrinology 37, 929–936 10.1016/j.psyneuen.2011.10.009
    1. Onur O. A., Walter H., Schlaepfer T. E., Rehme A. K., Schmidt C., Keysers C., et al. (2009). Noradrenergic enhancement of amygdala responses to fear. Soc. Cogn. Affect. Neurosci. 4, 119–126 10.1093/scan/nsn049
    1. Otte C., Neylan T. C., Pole N., Metzler T., Best S., Henn-Haase C., et al. (2005). Association between childhood trauma and catecholamine response to psychological stress in police academy recruits. Biol. Psychiatry 57, 27–32 10.1016/j.biopsych.2004.10.009
    1. Overmier J. B., Seligman M. E. (1967). Effects of inescapable shock upon subsequent escape and avoidance responding. J. Comp. Physiol. Psychol. 63, 28–33
    1. Ozbay F., Fitterling H., Charney D., Southwick S. (2008). Social support and resilience to stress across the life span: a neurobiologic framework. Curr. Psychiatry Rep. 10, 304–310
    1. Paez-Pereda M., Hausch F., Holsboer F. (2011). Corticotropin releasing factor receptor antagonists for major depressive disorder. Expert Opin. Investig. Drugs 20, 519–535 10.1517/13543784.2011.565330
    1. Parker K. J., Buckmaster C. L., Justus K. R., Schatzberg A. F., Lyons D. M. (2005). Mild early life stress enhances prefrontal-dependent response inhibition in monkeys. Biol. Psychiatry 57, 848–855 10.1016/j.biopsych.2004.12.024
    1. Parker K. J., Buckmaster C. L., Schatzberg A. F., Lyons D. M. (2004). Prospective investigation of stress inoculation in young monkeys. Arch. Gen. Psychiatry 61, 933–941 10.1001/archpsyc.61.9.933
    1. Paul N. A., Stanton S. J., Greeson J. M., Smoski M. J., Wang L. (2013). Psychological and neural mechanisms of trait mindfulness in reducing depression vulnerability. Soc. Cogn. Affect. Neurosci. 8, 56–64 10.1093/scan/nss070
    1. Pei L., Li S., Wang M., Diwan M., Anisman H., Fletcher P. J., et al. (2010). Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects. Nat. Med. 16, 1393–1395 10.1038/nm.2263
    1. Peters J., Dieppa-Perea L. M., Melendez L. M., Quirk G. J. (2010). Induction of fear extinction with hippocampal-infralimbic BDNF. Science 328, 1288–1290 10.1126/science.1186909
    1. Petersen A., Wortwein G., Gruber S. H., El-Khoury A., Mathe A. A. (2009). Nortriptyline mediates behavioral effects without affecting hippocampal cytogenesis in a genetic rat depression model. Neurosci. Lett. 451, 148–151 10.1016/j.neulet.2008.12.046
    1. Pietrzak R. H., Johnson D. C., Goldstein M. B., Malley J. C., Rivers A. J., Morgan C. A., et al. (2010). Psychosocial buffers of traumatic stress, depressive symptoms, and psychosocial difficulties in veterans of Operations Enduring Freedom and Iraqi Freedom: the role of resilience, unit support, and postdeployment social support. J. Affect. Disord. 120, 188–192 10.1016/j.jad.2009.04.015
    1. Pizzagalli D. A., Holmes A. J., Dillon D. G., Goetz E. L., Birk J. L., Bogdan R., et al. (2009). Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am. J. Psychiatry 166, 702–710 10.1176/appi.ajp.2008.08081201
    1. Poulter M. O., Du L., Weaver I. C., Palkovits M., Faludi G., Merali Z., et al. (2008). GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biol. Psychiatry 64, 645–652 10.1016/j.biopsych.2008.05.028
    1. Price L. H., Kao H. T., Burgers D. E., Carpenter L. L., Tyrka A. R. (2013). Telomeres and early-life stress: an overview. Biol. Psychiatry 73, 15–23 10.1016/j.biopsych.2012.06.025
    1. Ptacek R., Kuzelova H., Stefano G. B. (2011). Dopamine D4 receptor gene DRD4 and its association with psychiatric disorders. Med. Sci. Monit. 17, RA215–RA220
    1. Quirk G. J., Mueller D. (2008). Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33, 56–72 10.1038/sj.npp.1301555
    1. Radley J. J., Kabbaj M., Jacobson L., Heydendael W., Yehuda R., Herman J. P. (2011). Stress risk factors and stress-related pathology: neuroplasticity, epigenetics and endophenotypes. Stress 14, 481–497 10.3109/10253890.2011.604751
    1. Rakofsky J. J., Ressler K. J., Dunlop B. W. (2012). BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity. Mol. Psychiatry 17, 22–35 10.1038/mp.2011.121
    1. Rasmusson A. M., Schnurr P. P., Zukowska Z., Scioli E., Forman D. E. (2010). Adaptation to extreme stress: post-traumatic stress disorder, neuropeptide Y and metabolic syndrome. Exp. Biol. Med. (Maywood) 235, 1150–1162 10.1258/ebm.2010.009334
    1. Rattiner L. M., Davis M., French C. T., Ressler K. J. (2004). Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. J. Neurosci. 24, 4796–4806 10.1523/JNEUROSCI.5654-03.2004
    1. Rende R. (2012). Behavioral resilience in the post-genomic era: emerging models linking genes with environment. Front. Hum. Neurosci. 6:50 10.3389/fnhum.2012.00050
    1. Richardson G. E. (2002). The metatheory of resilience and resiliency. J. Clin. Psychol. 58, 307–321
    1. Rusiecki J. A., Chen L., Srikantan V., Zhang L., Yan L., Polin M. L., et al. (2012). DNA methylation in repetitive elements and post-traumatic stress disorder: a case-control study of US military service members. Epigenomics 4, 29–40 10.2217/epi.11.116
    1. Russo S. J., Murrough J. W., Han M. H., Charney D. S., Nestler E. J. (2012). Neurobiology of resilience. Nat. Neurosci. 15, 1475–1484 10.1038/nn.3234
    1. Rutter M. (1993). Resilience: some conceptual considerations. J. Adolesc. Health 14, 626–631, 690–696.
    1. Rutter M. (2012a). Annual research review: resilience: clinical implications. J. Child Psychol. Psychiatry. [Epub ahead of print]. 10.1111/j.1469-7610.2012.02615.x
    1. Rutter M. (2012b). Resilience as a dynamic concept. Dev. Psychopathol. 24, 335–344 10.1017/S0954579412000028
    1. Sah R., Geracioti T. D. (2012). Neuropeptide Y and posttraumatic stress disorder. Mol. Psychiatry. [Epub ahead of print]. 10.1038/mp.2012.101
    1. Sah R., Ekhator N. N., Strawn J. R., Sallee F. R., Baker D. G., Horn P. S., et al. (2009). Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder. Biol. Psychiatry 66, 705–707 10.1016/j.biopsych.2009.04.037
    1. Sailer U., Robinson S., Fischmeister F. P., Konig D., Oppenauer C., Lueger-Schuster B., et al. (2008). Altered reward processing in the nucleus accumbens and mesial prefrontal cortex of patients with posttraumatic stress disorder. Neuropsychologia 46, 2836–2844 10.1016/j.neuropsychologia.2008.05.022
    1. Sajdyk T. J., Shekhar A., Gehlert D. R. (2004). Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides 38, 225–234 10.1016/j.npep.2004.05.006
    1. Sanacora G., Treccani G., Popoli M. (2012). Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 62, 63–77 10.1016/j.neuropharm.2011.07.036
    1. Sapienza J. K., Masten A. S. (2011). Understanding and promoting resilience in children and youth. Curr. Opin. Psychiatry 24, 267–273 10.1097/YCO.0b013e32834776a8
    1. Scheier M. F., Matthews K. A., Owens J. F., Magovern G. J., Sr., Lefebvre R. C., Abbott R. A., et al. (1989). Dispositional optimism and recovery from coronary artery bypass surgery: the beneficial effects on physical and psychological well-being. J. Pers. Soc. Psychol. 57, 1024–1040 10.1037/0022-3514.57.6.1024
    1. Schlaepfer T. E., Cohen M. X., Frick C., Kosel M., Brodesser D., Axmacher N., et al. (2008). Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 33, 368–377 10.1038/sj.npp.1301408
    1. Schmidt U., Holsboer F., Rein T. (2011). Epigenetic aspects of posttraumatic stress disorder. Dis. Markers 30, 77–87 10.3233/DMA-2011-0749
    1. Segman R. H., Cooper-Kazaz R., Macciardi F., Goltser T., Halfon Y., Dobroborski T., et al. (2002). Association between the dopamine transporter gene and posttraumatic stress disorder. Mol. Psychiatry 7, 903–907 10.1038/sj.mp.4001085
    1. Seligman M. E., Maier S. F. (1967). Failure to escape traumatic shock. J. Exp. Psychol. 74, 1–9
    1. Shin L. M., Liberzon I. (2010). The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 35, 169–191 10.1038/npp.2009.83
    1. Skelton K., Ressler K. J., Norrholm S. D., Jovanovic T., Bradley-Davino B. (2012). PTSD and gene variants: new pathways and new thinking. Neuropharmacology 62, 628–637 10.1016/j.neuropharm.2011.02.013
    1. Smith B. W., Ortiz J. A., Steffen L. E., Tooley E. M., Wiggins K. T., Yeater E. A., et al. (2011). Mindfulness is associated with fewer PTSD symptoms, depressive symptoms, physical symptoms, and alcohol problems in urban firefighters. J. Consult. Clin. Psychol. 79, 613–617 10.1037/a0025189
    1. Snow-Turek A. L., Norris M. P., Tan G. (1996). Active and passive coping strategies in chronic pain patients. Pain 64, 455–462 10.1016/0304-3959(95)00190-5
    1. Solomon Z., Karni G., Yuval N., Abraham O. (1995). Coping with war captivity: the role of sensation seeking. Eur. J. Pers. 9, 57–70
    1. Southwick S. M., Charney D. S. (2012). The science of resilience: implications for the prevention and treatment of depression. Science 338, 79–82 10.1126/science.1222942
    1. Southwick S. M., Vythilingam M., Charney D. S. (2005). The psychobiology of depression and resilience to stress: implications for prevention and treatment. Annu. Rev. Clin. Psychol. 1, 255–291 10.1146/annurev.clinpsy.1.102803.143948
    1. Staub E., Vollhardt J. (2008). Altruism born of suffering: the roots of caring and helping after victimization and other trauma. Am. J. Orthopsychiatry 78, 267–280 10.1037/a0014223
    1. Stewart D. E., Yuen T. (2011). A systematic review of resilience in the physically ill. Psychosomatics 52, 199–209 10.1016/j.psym.2011.01.036
    1. Strawn J. R., Geracioti T. D., Jr. (2008). Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depress. Anxiety 25, 260–271 10.1002/da.20292
    1. Strome E. M., Wheler G. H., Higley J. D., Loriaux D. L., Suomi S. J., Doudet D. J. (2002). Intracerebroventricular corticotropin-releasing factor increases limbic glucose metabolism and has social context-dependent behavioral effects in nonhuman primates. Proc. Natl. Acad. Sci. U.S.A. 99, 15749–15754 10.1073/pnas.232480899
    1. Sun H., Kennedy P. J., Nestler E. J. (2013). Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacology 38, 124–137 10.1038/npp.2012.73
    1. Taliaz D., Loya A., Gersner R., Haramati S., Chen A., Zangen A. (2011). Resilience to chronic stress is mediated by hippocampal brain-derived neurotrophic factor. J. Neurosci. 31, 4475–4483 10.1523/JNEUROSCI.5725-10.2011
    1. Taylor S. E., Stanton A. L. (2007). Coping resources, coping processes, and mental health. Annu. Rev. Clin. Psychol. 3, 377–401 10.1146/annurev.clinpsy.3.022806.091520
    1. Thompson R. W., Arnkoff D. B., Glass C. R. (2011). Conceptualizing mindfulness and acceptance as components of psychological resilience to trauma. Trauma. Violence Abuse 12, 220–235 10.1177/1524838011416375
    1. Troy A. S., Wilhelm F. H., Shallcross A. J., Mauss I. B. (2010). Seeing the silver lining: cognitive reappraisal ability moderates the relationship between stress and depressive symptoms. Emotion 10, 783–795 10.1037/a0020262
    1. Tsai J., Harpaz-Rotem I., Pietrzak R. H., Southwick S. M. (2012). The role of coping, resilience, and social support in mediating the relation between PTSD and social functioning in veterans returning from Iraq and Afghanistan. Psychiatry 75, 135–149 10.1521/psyc.2012.75.2.135
    1. Tsankova N., Renthal W., Kumar A., Nestler E. J. (2007). Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci. 8, 355–367
    1. Uddin M., Galea S., Chang S. C., Aiello A. E., Wildman D. E., De Los Santos R., et al. (2011). Gene expression and methylation signatures of MAN2C1 are associated with PTSD. Dis. Markers 30, 111–121 10.3233/DMA-2011-0750
    1. Vaillant G. E. (1992). The historical origins and future potential of Sigmund Freud's concept of the mechanisms of defence. Int. J. Psychoanal. 19, 35–50
    1. Vythilingam M., Nelson E. E., Scaramozza M., Waldeck T., Hazlett G., Southwick S. M., et al. (2009). Reward circuitry in resilience to severe trauma: an fMRI investigation of resilient special forces soldiers. Psychiatry Res. 172, 75–77 10.1016/j.pscychresns.2008.06.008
    1. Warner L. M., Schwarzer R., Schuz B., Wurm S., Tesch-Romer C. (2012). Health-specific optimism mediates between objective and perceived physical functioning in older adults. J. Behav. Med. 35, 400–406 10.1007/s10865-011-9368-y
    1. Weaver I. C., Cervoni N., Champagne F. A., D'Alessio A. C., Sharma S., Seckl J. R., et al. (2004). Epigenetic programming by maternal behavior. Nat. Neurosci. 7, 847–854
    1. Werner E. E. (2012). Children and war: risk, resilience, and recovery. Dev. Psychopathol. 24, 553–558 10.1017/S0954579412000156
    1. Wethington H. R., Hahn R. A., Fuqua-Whitley D. S., Sipe T. A., Crosby A. E., Johnson R. L., et al. (2008). The effectiveness of interventions to reduce psychological harm from traumatic events among children and adolescents: a systematic review. Am. J. Prev. Med. 35, 287–313 10.1016/j.amepre.2008.06.024
    1. Winter B., Breitenstein C., Mooren F. C., Voelker K., Fobker M., Lechtermann A., et al. (2007). High impact running improves learning. Neurobiol. Learn. Mem. 87, 597–609 10.1016/j.nlm.2006.11.003
    1. Wittert G. A., Livesey J. H., Espiner E. A., Donald R. A. (1996). Adaptation of the hypothalamopituitary adrenal axis to chronic exercise stress in humans. Med. Sci. Sports Exerc. 28, 1015–1019
    1. Wong A. H., Liu F. (2012). Uncoupling the dopamine D1-D2 receptor complex: a novel target for antidepressant treatment. Clin. Pharmacol. Ther. 91, 298–302 10.1038/clpt.2011.311
    1. Wu G., Feder A., Wegener G., Bailey C., Saxena S., Charney D., et al. (2011). Central functions of neuropeptide Y in mood and anxiety disorders. Expert Opin. Ther. Targets 15, 1317–1331 10.1517/14728222.2011.628314
    1. Xie P., Kranzler H. R., Poling J., Stein M. B., Anton R. F., Brady K., et al. (2009). Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. Arch. Gen. Psychiatry 66, 1201–1209 10.1001/archgenpsychiatry.2009.153
    1. Yamada K., Nabeshima T. (2003). Brain-derived neurotrophic factor/TrkB signaling in memory processes. J. Pharmacol. Sci. 91, 267–270 10.1254/jphs.91.267
    1. Yehuda R., Brand S., Yang R. K. (2006). Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping. Biol. Psychiatry 59, 660–663 10.1016/j.biopsych.2005.08.027
    1. Zhang K., Rao F., Pablo Miramontes-Gonzalez J., Hightower C. M., Vaught B., Chen Y., et al. (2012). Neuropeptide, Y (NPY): genetic variation in the human promoter alters glucocorticoid signaling, yielding increased NPY secretion and stress responses. J. Am. Coll. Cardiol. 60, 1678–1689 10.1016/j.jacc.2012.06.042
    1. Zhou Z., Zhu G., Hariri A. R., Enoch M. A., Scott D., Sinha R., et al. (2008). Genetic variation in human NPY expression affects stress response and emotion. Nature 452, 997–1001 10.1038/nature06858
    1. Zimmerman J. M., Maren S. (2010). NMDA receptor antagonism in the basolateral but not central amygdala blocks the extinction of Pavlovian fear conditioning in rats. Eur. J. Neurosci. 31, 1664–1670 10.1111/j.1460-9568.2010.07223.x
    1. Zimmermann P., Bruckl T., Nocon A., Pfister H., Binder E. B., Uhr M., et al. (2011). Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. Am. J. Psychiatry 168, 1107–1116 10.1176/appi.ajp.2011.10111577

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit